Cell Reports Medicine SCIE

國(guó)際簡(jiǎn)稱：Cell Rep Med 參考譯名：細(xì)胞醫(yī)學(xué)報(bào)道

主要研究方向：Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all) 非預(yù)警期刊審稿周期：約Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks

《細(xì)胞醫(yī)學(xué)報(bào)道》(Cell Reports Medicine)是一本由Elsevier出版的以Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽(yù)，影響因子不斷增加，發(fā)行量也同樣高。

1區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
305 年發(fā)文量
11.7 IF影響因子
開(kāi)放 是否OA
2020 創(chuàng)刊年份
Monthly 出版周期
English 出版語(yǔ)言

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

[ 查看全部 ]

投稿咨詢加急咨詢

Cell Reports Medicine期刊信息

ISSN：2666-3791
出版語(yǔ)言：English
是否OA：開(kāi)放
E-ISSN：2666-3791
出版地區(qū)：United States
是否預(yù)警：否
出版商：Elsevier
出版周期：Monthly
創(chuàng)刊時(shí)間：2020
開(kāi)源占比：0.8876
Gold OA文章占比：93.57%
OA被引用占比：
出版國(guó)人文章占比：0
出版撤稿占比：
研究類文章占比：95.74%

Cell Reports Medicine CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

4.276

1.664

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：General Medicine	Q1	25 / 636	96%
大類：Medicine 小類：General Biochemistry, Genetics and Molecular Biology	Q1	18 / 221	92%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。

Cell Reports Medicine中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) CELL BIOLOGY 細(xì)胞生物學(xué)	1區(qū) 2區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) CELL BIOLOGY 細(xì)胞生物學(xué)	1區(qū) 2區(qū)

Cell Reports Medicine JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL BIOLOGY	SCIE	Q1	22 / 205	89.5%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	10 / 189	95%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CELL BIOLOGY	SCIE	Q1	14 / 205	93.41%
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	8 / 189	96.03%

Cell Reports Medicine歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Cell Reports Medicine中國(guó)學(xué)者發(fā)文選摘

1、Current understanding of the intratumoral microbiome in various tumors
Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100884
2、Inherited mutations in Chinese patients with upper tract urothelial carcinoma
Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100883
3、Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100881
4、Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET
Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100934
5、Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Author: Wang, Han-Min; Zhang, Chan-Yuan; Peng, Kai-Cheng; Chen, Ze-Xin; Su, Jun-Wei; Li, Yu-Fa; Li, Wen-Feng; Gao, Qing-Yun; Zhang, Shi-Ling; Chen, Yu-Qing; Zhou, Qing; Xu, Cong; Xu, Chong-Rui; Wang, Zhen; Su, Jian; Yan, Hong-Hong; Zhang, Xu-Chao; Chen, Hua-Jun; Wu, Yi-Long; Yang, Jin-Ji

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100911
6、Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
Author: Tian, Xiao-Peng; Zhang, Yu-Chen; Lin, Ning-Jing; Wang, Liang; Li, Zhi-Hua; Guo, Han-Guo; Ma, Shu-Yun; An, Ming-Jie; Yang, Jing; Hong, Yu-Heng; Wang, Xian-Huo; Zhou, Hui; Li, Ya-Jun; Rao, Hui-Lan; Li, Mei; Hu, Shao-Xuan; Lin, Tong-Yu; Li, Zhi-Ming; Huang, He; Liang, Yang; Xia, Zhong-Jun; Lv, Yue; Liu, Yu-Ying; Duan, Zhao-Hui; Chen, Qing-Yu; Wang, Jin-Ni; Cai, Jun; Xie, Ying; Ong, Choon-Kiat; Liu, Fang; Liu, Yan-yan; Yan, Zheng; Huang, Liang; Tao, Rong; Li, Wen-Yu; Huang, Hui-Qiang; Cai, Qing-Qing

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100859
7、Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer
Author: Tang, Zhaoqing; Gu, Yuan; Shi, Zhongyi; Min, Lingqiang; Zhang, Ziwei; Zhou, Peng; Luo, Rongkui; Wang, Yan; Cui, Yuehong; Sun, Yihong; Wang, Xuefei

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100931
8、DeepFundus: A flow-cytometry-like image quality classifier for boosting the whole life cycle of medical artificial intelligence
Author: Liu, Lixue; Wu, Xiaohang; Lin, Duoru; Zhao, Lanqin; Li, Mingyuan; Yun, Dongyuan; Lin, Zhenzhe; Pang, Jianyu; Li, Longhui; Wu, Yuxuan; Lai, Weiyi; Xiao, Wei; Shang, Yuanjun; Feng, Weibo; Tan, Xiao; Li, Qiang; Liu, Shenzhen; Lin, Xinxin; Sun, Jiaxin; Zhao, Yiqi; Yang, Ximei; Ye, Qinying; Zhong, Yuesi; Huang, Xi; He, Yuan; Fu, Ziwei; Xiang, Yi; Zhang, Li; Zhao, Mingwei; Qu, Jinfeng; Xu, Fan; Lu, Peng; Li, Jianqiao; Xu, Fabao; Wei, Wenbin; Dong, Li; Dai, Guangzheng; He, Xingru; Yan, Wentao; Zhu, Qiaolin; Lu, Linna; Zhang, Jiaying; Zhou, Wei; Meng, Xiangda; Li, Shiying; Shen, Mei; Jiang, Qin; Chen, Nan; Zhou, Xingtao; Li, Meiyan; Wang, Yan; Zou, Haohan; Zhong, Hua; Yang, Wenyan; Shou, Wulin; Zhong, Xingwu; Yang, Zhenduo; Ding, Lin; Hu, Yongcheng; Tan, Gang; He, Wanji; Zhao, Xin; Chen, Yuzhong; Liu, Yizhi; Lin, Haotian

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100912